Liver Fibrosis Market Size To Hit US$ 4,897.7 Million By 2033
According to IMARC Group’s latest report, titled “Liver Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”, the 7 major liver fibrosis markets reached a value of US$ 2,152.0 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 4,897.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.7% during 2023-2033. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Request for a Free Sample Copy of this Report:
https://www.imarcgroup.com/liver-fibrosis-market/requestsample
Industry Definition and Application:
Liver fibrosis, characterized by excessive scar tissue in the liver following damage, leads to stiffness and diminished organ functionality over time. Early symptoms include decreased appetite, mental fog, leg and abdominal fluid buildup, breathlessness, nausea, unexplained weight loss, and muscle weakness. Advanced stages involve jaundice, confusion, hormonal imbalance, bruising, dark-colored urine, and gastrointestinal bleeding. Diagnosing this disease involves analyzing the patient's medical history, identifying symptoms, and running a range of blood tests. Additional diagnostic procedures like ultrasonography, computed tomography, and magnetic resonance imaging are employed to observe hepatic parenchymal alterations linked to moderate-to-severe stages of the disease. A liver biopsy and histological analysis are recommended for grading the neuroinflammatory stages and evaluating the severity of fibrosis.
What are the growth prospects and trends in the industry?
The liver fibrosis market is
expanding, driven mainly by the growing occurrence of liver injury and
inflammation leading to excess protein accumulation. The increasing prevalence
of risk factors like high alcohol consumption, obesity, and autoimmune
hepatitis also significantly contributes to market growth. The uptick in the use
of antifibrotic drugs such as belapectin, cenicriviroc, and liraglutide to
prevent irreversible liver scarring is further propelling this growth. The elevating
application of next-gen plasma protein profiling to identify liver fibrosis
biomarkers and devise personalized treatment approaches provides a positive
market outlook. Additionally, cell therapy's demand is on the rise for treating
liver fibrosis, as it mends or substitutes damaged liver cells and boosts
hepatic enzyme production, enhancing patients' quality of life. This trend is
likely to continue, augmenting the liver fibrosis market in the future.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the liver fibrosis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the liver fibrosis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the liver fibrosis marketed drugs and late-stage pipeline drugs.
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7697&flag=C
Competitive Landscape With Key Players:
The competitive landscape of the liver fibrosis market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2033)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
